KLF1 Antibody (C-Term)
Purified Rabbit Polyclonal Antibody (Pab)
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, E |
---|---|
Primary Accession | Q13351 |
Reactivity | Human |
Host | Rabbit |
Clonality | polyclonal |
Isotype | Rabbit Ig |
Calculated MW | 38221 Da |
Gene ID | 10661 |
---|---|
Other Names | Krueppel-like factor 1, Erythroid krueppel-like transcription factor, EKLF, KLF1, EKLF |
Target/Specificity | This KLF1 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between amino acids from the human region of human KLF1. |
Dilution | WB~~1:1000 |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | KLF1 Antibody (C-Term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | KLF1 |
---|---|
Synonyms | EKLF |
Function | Transcription regulator of erythrocyte development that probably serves as a general switch factor during erythropoiesis. Is a dual regulator of fetal-to-adult globin switching. Binds to the CACCC box in the beta-globin gene promoter and acts as a preferential activator of this gene. Furthermore, it binds to the BCL11A promoter and activates expression of BCL11A, which in turn represses the HBG1 and HBG2 genes. This dual activity ensures that, in most adults, fetal hemoglobin levels are low. Able to activate CD44 and AQP1 promoters. When sumoylated, acts as a transcriptional repressor by promoting interaction with CDH2/MI2beta and also represses megakaryocytic differentiation. |
Cellular Location | Nucleus. Note=Colocalizes with SUMO1 in nuclear speckles. |
Tissue Location | Expression restricted to adult bone marrow and fetal liver. Not expressed in myeloid nor lymphoid cell lines |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Transcription regulator of erythrocyte development that probably serves as a general switch factor during erythropoiesis. Is a dual regulator of fetal-to-adult globin switching. Binds to the CACCC box in the beta-globin gene promoter and acts as a preferential activator of this gene. Furthermore, it binds to the BCL11A promoter and activates expression of BCL11A, which in turn represses the HBG1 and HBG2 genes. This dual activity ensures that, in most adults, fetal hemoglobin levels are low. Able to activate CD44 and AQP1 promoters. When sumoylated, acts as a transcriptional repressor by promoting interaction with CDH2/MI2beta and also represses megakaryocytic differentiation.
References
Bieker J.J.,et al.DNA Cell Biol. 15:347-352(1996).
van Ree J.H.,et al.Genomics 39:393-395(1997).
Grimwood J.,et al.Nature 428:529-535(2004).
Zhang W.,et al.Proc. Natl. Acad. Sci. U.S.A. 95:9855-9860(1998).
Arnaud L.,et al.Am. J. Hum. Genet. 87:721-727(2010).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.